Skip to content
Our latest insights, reports and media
What We Heard from the SFO: Six Takeaways for Compliance Leaders
At a recent Ethixbase360 executive roundtable in London, senior compliance, legal and risk leaders joined Michael Leo Gallagher, Chief Investigator at the UK’s Serious...
Learn More
What Compliance Teams Need to Know: Human Rights Due Diligence and Modern Slavery in 2026
Over the past two months, Ethixbase360 and Norton Rose Fulbright hosted a two-part webinar series on Human Rights Due Diligence (HRDD) and […]
Learn More
Five Key Takeaways from Our Webinar on Ownership Transparency and Sanctions Risk
Beneficial ownership transparency has long been a challenge for compliance teams. But as sanctions enforcement intensifies, regulatory expectations evolve [...]
Learn More
Third-Party Risk in an Age of Engineered Volatility and Fragmentation
Third-party risk is no longer a static assessment. Volatility and fragmentation — geopolitical and economic — are being actively engineered, reshaping the risks facing...
Learn More
What the Epstein Case Reveals About Reputational Risk and Third-Party Due Diligence
The recent Ethixbase360 webinar, Reputational Risk and Third-Party Exposure: Compliance Lessons from the Epstein Files, explored what one of the most high-profile reputational scandals...
Learn More
A Practical Guide to Third-Party Cyber Risk Management
Cyber risk is no longer contained within your organisation. Today’s most damaging breaches don’t start with you, they start with the third parties you...
Learn More
Compliance Implications of Anthropic’s Dispute with the Pentagon
In late February 2026, the US Department of Defense (DoD) designated the artificial intelligence (AI) company Anthropic a supply chain risk, a first for...
Learn More
Key Takeaways from our Webinar: Managing Human Rights and Corruption Risks Across Life Sciences Third Parties
Key Takeaways from our Webinar: Managing Human Rights and Corruption Risks Across Life Sciences Third Parties In Partnership with Ethics and Compliance Switzerland. [...]
Learn More
Key Takeaways from Our London Roundtable: Human Rights Due Diligence in Pharma
We recently hosted a pharma-focused roundtable in partnership with Norton Rose Fulbright at their London office, bringing together senior risk and compliance professionals from...
Learn More